Audio Interviews

ValueTheMarkets Podcast 022 – with Kieran Callan, CEO of InnovaDerma (IDP)

02 Oct 2019 | by: Richard Mason

Today’s guest on the ValueTheMarkets podcast is Kieran Callan, CEO of InnovaDerma (LSE:IDP). InnovaDerma is a developer of life sciences and personal care products with a number of existing products already available through retail outlets such as Superdrug and Boots. The firm’s existing brands include Skinny Tan, Roots, Prolong and Grow Lase and it is looking to extend its range of products.

InnovaDerma released it’s FY2019 final results on 24th September revealing profits before tax had risen 100pc year-on-year to £1.4m. Kieran discusses the company’s expansion plans, its strong business to customer sales, and why he believes the market is yet to price in InnovaDerma’s future growth.

All opinions expressed are those of ValueTheMarkets and the respective guests unless otherwise stated and should not be construed as investment advice or a recommendation to buy shares in any featured Company. Listeners are advised to do their own extensive research before buying shares which, as with all small-cap exploration stocks, should be viewed as high risk. Investors should also seek the advice of a qualified investment adviser or stockbroker as they deem appropriate., Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

  • Digitonic Ltd, the owner of, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.
  • Digitonic Ltd, the owner of, has not been paid for the production of this piece by the company or companies mentioned above.

More News & Analysis